Please subscribe to our email alerts to be the first to hear about upcoming challenges!
Open Innovation
Accelerating research and scientific innvoation through collaboration
At AstraZeneca, we are committed to pushing the boundaries of science to deliver life-changing medicines. But we cannot achieve this alone. By joining forces with external researchers like you, we can combine our resources, advance innovative science, and accelerate the discovery of next-generation therapeutics, together.
We want to be the best scientific partners you have. We want to help you take your ideas and turn them into something that can be translated into medicines for patients.
At AstraZeneca, we know that to address all the issues facing healthcare and achieve the scientific breakthroughs we aspire to, collaboration is essential.
Through our Open Innovation programme, we share our compounds, tools, technologies and expertise with the scientific community to advance drug discovery and development.
- Collapse all
Our Open Innovation programme offers many collaboration opportunities for you to advance your research – from optimised compounds with extensive data packages to high-throughput screening libraries and facilities. We believe that combining our drug R&D knowhow, expertise and experience with your in-depth knowledge of disease, models and much more provides opportunities to accelerate science. Sharing ideas and enabling scientific innovation to cross boundaries between academia and industry will help to translate innovative ideas into scientific breakthroughs and potential new medicines more quickly.
Our way of working at Astrazeneca is inclusive, open and collaborative. We aim to create mutually beneficial partnerships founded on trust and transparency.
Through Open Innovation, we want to work with scientists and researchers anywhere in the world that have a great idea and where we think we can help translate that idea into the medicines of the future. We work hard to ensure that both parties receive the greatest possible value from the relationship.
We know it takes time to put a proposal together so we endeavour to give it the attention it deserves when evaluating potential collaborations.
All submissions undergo a through internal review process, with therapy, disease or technology experts alongside our Open Innovation team.This process may take up to 8 weeks and our decision will then be communicated back to you.
If you are looking for other partnering opportunities not listed here (i.e. licensing), please visit the Astrazeneca partnering page to learn more.
Collaboration opportunities
